TELA Bio, Inc.
Surgical & Medical Instruments & Apparatus · MALVERN · PA
Moderate confidence (50%)
Updated Oct 20, 2026, 12:04 AM
What is happening
Derived by rule set status-rules-2026.09.7
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
Latest material event: TELA Bio, Inc. received a delisting notice from its exchange (Sep 15, 2026)
Timeline
Every material event, newest first. History is never overwritten.
TELA Bio, Inc. received a delisting notice from its exchange
Sep 15, 2026
Delisting notice received
- SEC EDGAR — “Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. As previously disclosed, on March 17, 2026, TELA Bio, Inc. (the Company ) received a letter from the Listing Qualifications Department (the Staff ) of The Nasdaq Stock Market LLC ( Nasdaq ) notifying the Company that the listing of its common stock was not in compliance with Nasdaq Listing Rule 5450(a)(1) for continued listing on The Nasdaq Global Market, as the minimum bid price of the Company s common stock was less than $1.00 per share for the previous 30 consecutive business days…”
Company information
- Founded
- —
- Employees (estimate)
- —
- Industry
- Surgical & Medical Instruments & Apparatus
- Subindustry
- —
- Listing
- SEC lists the ticker TELA on Nasdaq.
- SEC CIK
- 0001561921
- Website
- —
- —
- Headquarters
- MALVERN, PA
- Also known as
- —
- Legal entities
- TELA Bio, Inc.
Sources
Every material source used to build this profile.
SEC Company Submissions (TIER 1 · UNVERIFIED)
TELA Bio, Inc. — Surgical & Medical Instruments & Apparatus (SIC 3841) — MALVERN, PA
View source recordSEC EDGAR (TIER 1 · UNVERIFIED)
Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. As previously disclosed, on March 17, 2026, TELA Bio, Inc. (the Company ) received a letter from the Listing Qualifications Department (the Staff ) of The Nasdaq Stock Market LLC ( Nasdaq ) notifying the Company that the listing of its common stock was not in compliance with Nasdaq Listing Rule 5450(a)(1) for continued listing on The Nasdaq Global Market, as the minimum bid price of the Company s common stock was less than $1.00 per share for the previous 30 consecutive business days…
View source record
Status history
Every derived status, with the rule that produced it.
- UNKNOWN → DISTRESS_SIGNALLISTING_STANDARDS_WARNING · Sep 20, 2026, 12:14 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.